The short answer
Aloe has not been shown to increase the absorption or blood levels of injected regular human insulin. An intestinal-cell experiment does not establish that clinical interaction.
What this answer covers
Oral aloe gel or whole-leaf products versus injected human regular insulin. Topical gel, laxative latex and experimental oral-insulin formulations are different exposures.
- Supplement or preparation
- Aloe vera
- Medication ingredient
- insulin, regular, human
The absorption experiment used cells
A laboratory study found increased insulin transport across cultured intestinal cells exposed to aloe preparations. It investigated a possible way to improve oral drug delivery, not what happens after a patient injects insulin.
The route changes the interpretation
Regular human insulin is injected under the skin, or in the case of appropriate U-100 formulations given intravenously under medical supervision. Intestinal transport cannot demonstrate increased absorption from an injection site or higher injected-insulin levels.
Glucose changes answer a different question
A small aloe-gel trial improved glucose measures with glyburide and metformin and reported no adverse effects in its abstract. It did not measure regular-insulin exposure. Gel, whole leaf and latex should not be treated as interchangeable.
Keep the prescribed insulin plan
Discuss oral aloe use with the diabetes team and follow your glucose-monitoring plan. Do not change insulin based on the cell experiment. U-100 and U-500 have different concentration and route instructions, and no aloe-spacing rule is established.
Evidence and practical considerations
Absorption & effectiveness
Intestinal-cell transport findings do not establish increased absorption or levels of injected regular human insulin; clinical glucose benefit is not pharmacokinetic proof.
- Exact scope
- Oral aloe gel or whole-leaf products versus injected human regular insulin. Topical gel, laxative latex and experimental oral-insulin formulations are different exposures. with Regular human insulin RxCUI253182 IN; U100/U500 and routes distinct.
- Medication form and route
- injected regular human insulin; oral supplement
What remains uncertain
- No exact herb-event rate or arbitrary insulin change.
Factors that may matter: Concentration; Route; Meals; Product; Other diabetes treatment.
Read the supporting source summaries
Source 1: current product label
dailymed.nlm.nih.gov · Source check Sep 10, 2026
Population: People prescribed regular human insulin
Hypoglycemia can be severe. Niacin may decrease glucose lowering. Treatment changes can require increased monitoring and clinician review. Subcutaneous dose given30minutes before meals.
How this applies: Exact RxCUI253182 IN regular human insulin; U100/U500 distinguished from NPH and rapid analogs.
Product concentration, devices, route and action profile matter. No supplement-specific adverse-event incidence.
Source 2: current product label
dailymed.nlm.nih.gov · Source check Sep 10, 2026
Population: People prescribed regular human insulin
Hypoglycemia can be severe. Niacin may decrease glucose lowering. Treatment changes can require increased monitoring and clinician review. Subcutaneous dose given30minutes before meals. Concentration gives a different time course with both prandial and basal activity.
How this applies: Exact RxCUI253182 IN regular human insulin; U100/U500 distinguished from NPH and rapid analogs.
Product concentration, devices, route and action profile matter. No supplement-specific adverse-event incidence.
Source 3: original human study
pubmed.ncbi.nlm.nih.gov · Source check Sep 10, 2026
Population: Hyperlipidemic type2diabetes adults;30aloe and30placebo.
Aloe gel improved glucose measures with oral diabetes medicines; no adverse effects reported in the abstract.
How this applies: Indirect for regular human insulin; oral-drug glucose outcomes do not establish injected-insulin pharmacokinetics.
Not regular human insulin. Small trial and absence of reported adverse effects do not establish a hypoglycemia risk rate or cover latex/whole-leaf products.
Source 4: Federal supplement guidance
nccih.nih.gov · Source check Sep 10, 2026
Population: People considering different Aloe vera products.
Guidance distinguishes oral preparations and describes limited glucose-lowering research; latex can cause abdominal pain, cramps and diarrhea.
How this applies: Indirect for regular human insulin; oral-drug glucose outcomes do not establish injected-insulin pharmacokinetics.
General guidance is not a glimepiride interaction study or evidence that different aloe products are interchangeable. This does not establish an exact regular-human-insulin interaction.
Source 5: original laboratory study
pubmed.ncbi.nlm.nih.gov · Source check Sep 10, 2026
Population: Caco-2 intestinal-cell monolayers; not treated patients
Aloe preparations increased insulin transport across cultured intestinal cells; junction effects were reversible.
How this applies: Mechanistic route mismatch explicitly excluded from clinical claim support.
In vitro intestinal model for potential oral drug delivery. Not subcutaneous absorption, intravenous exposure or a human supplement interaction; exact regular-insulin formulation unverified.
Research assessment: · Open full citations ↗
Review and change history
- Publication status
- Published research summary
- Clinical review
- Not yet recorded
| Date | Update |
|---|---|
| Article prepared | |
| Prepared exact regular-insulin article with route, concentration and clinical endpoint boundaries. | |
| Research summary published |
Article revision: 5e9f8a1ebbccf61c
This guide brings together the evidence records used by our interaction checker. Each finding retains its own preparation limits, research date, and source summaries.
Full citations require verification. Reading this answer and the source summaries does not.
Taking other supplements or medications?
Use the checker to explore your other combinations. Ask a pharmacist to review the exact products, amounts and medical conditions in your complete list.
Open the interaction checkerInformation, not medical advice. Do not change prescribed treatment based on this guide.